Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Hiemke

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Pharmacology|May 4, 2017
Making the Case for 'Power Abuse Disorder' as a Nosologic EntityGerald Zernig, Christoph Hiemke
Therapeutische Umschau. Revue Therapeutique|June 1, 2010
[Pharmacogenetics, therapeutic drug monitoring and non compliance]Viktoria Stieffenhofer, Christoph Hiemke
Pharmazie in Unserer Zeit|December 17, 2002
[Important to atypical antipsychotics: pharmacokinetics, interaction potential and therapeutic drug monitoring]Sebastian Härtter, Christoph Hiemke
Medizinische Monatsschrift Fur Pharmazeuten|June 6, 2003
[Therapeutic drug monitoring of new antidepressives and antipsychotics]Sebastian Härtter, Christoph Hiemke
Therapeutic Drug Monitoring|March 21, 2020
Dose-Related Concentrations of Neuroactive/Psychoactive Drugs Expected in Blood of Children and AdolescentsStefanie Fekete, Christoph Hiemke, Manfred Gerlach
Nordic Journal of Psychiatry|September 25, 2015
Consensus guideline for therapeutic drug monitoring in psychiatry (2004): Bibliometric analysis of citations for the period 2004-2011Andreas Schäfer, Christoph Hiemke, Pierrre Baumann
Psychopharmacology|April 13, 2011
Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transportersBritta Haenisch, Christoph Hiemke, Heinz Bönisch
The International Journal of Neuropsychopharmacology|August 7, 2009
Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attemptMichael Paulzen, Christoph Hiemke, Gerhard Gründer
Journal of Clinical Psychopharmacology|April 19, 2014
Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interactionGudrun Hefner, Katharina Geschke, Christoph Hiemke
Therapeutic Drug Monitoring|March 30, 2005
Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detectionJulia Sachse, Sebastian Härtter, Christoph Hiemke
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Pharmacology|May 4, 2017
Making the Case for 'Power Abuse Disorder' as a Nosologic EntityGerald Zernig, Christoph Hiemke
Therapeutische Umschau. Revue Therapeutique|June 1, 2010
[Pharmacogenetics, therapeutic drug monitoring and non compliance]Viktoria Stieffenhofer, Christoph Hiemke
Pharmazie in Unserer Zeit|December 17, 2002
[Important to atypical antipsychotics: pharmacokinetics, interaction potential and therapeutic drug monitoring]Sebastian Härtter, Christoph Hiemke
Medizinische Monatsschrift Fur Pharmazeuten|June 6, 2003
[Therapeutic drug monitoring of new antidepressives and antipsychotics]Sebastian Härtter, Christoph Hiemke
Therapeutic Drug Monitoring|March 21, 2020
Dose-Related Concentrations of Neuroactive/Psychoactive Drugs Expected in Blood of Children and AdolescentsStefanie Fekete, Christoph Hiemke, Manfred Gerlach
Nordic Journal of Psychiatry|September 25, 2015
Consensus guideline for therapeutic drug monitoring in psychiatry (2004): Bibliometric analysis of citations for the period 2004-2011Andreas Schäfer, Christoph Hiemke, Pierrre Baumann
Psychopharmacology|April 13, 2011
Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transportersBritta Haenisch, Christoph Hiemke, Heinz Bönisch
The International Journal of Neuropsychopharmacology|August 7, 2009
Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attemptMichael Paulzen, Christoph Hiemke, Gerhard Gründer
Journal of Clinical Psychopharmacology|April 19, 2014
Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interactionGudrun Hefner, Katharina Geschke, Christoph Hiemke
Therapeutic Drug Monitoring|March 30, 2005
Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detectionJulia Sachse, Sebastian Härtter, Christoph Hiemke
Pageof 24